MDT

AI Research

MiniMed IPO at $20/Share → Medtronic Trades at $87.38 with Buy Consensus

Medtronic's diabetes subsidiary MiniMed priced its IPO at $20 per share on March 5 and began trading on Nasdaq under MMED, reducing Medtronic's revenue base while generating capital. The company advanced its MiniMed Go Smart MDI system in Europe and declared a quarterly dividend of $0.71 per share. With 19 analysts rating it Buy and a stock price of $87.38, the MiniMed spin-off creates near-term uncertainty about Medtronic's long-term revenue trajectory.